Stay updated on Pembrolizumab in Esophagogastric Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Esophagogastric Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Esophagogastric Cancer Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    Added Carcinoma of esophagus as a condition term. Added a Resources link to the Genetic and Rare Diseases Information Center.
    Difference
    0.2%
    Check dated 2026-04-03T18:24:41.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    Added Revision: v3.5.0 and removed Revision: v3.4.3 as part of the site's versioning updates.
    Difference
    0.1%
    Check dated 2026-03-20T03:28:35.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    Revision: v3.4.3 was added in the revision history and Revision: v3.4.2 was removed. No impact on the study’s data or page usability.
    Difference
    0.1%
    Check dated 2026-03-12T21:30:32.000Z thumbnail image
  5. Check
    51 days ago
    Change Detected
    Summary
    - Revision updated from v3.4.1 to v3.4.2; a minor version change with no impact on study content or usability. - To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-12T02:02:14.000Z thumbnail image
  6. Check
    58 days ago
    Change Detected
    Summary
    Footer revision updated to v3.4.1, replacing v3.4.0; this is a minor metadata change that does not affect study content or page interactions. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-05T00:31:07.000Z thumbnail image
  7. Check
    65 days ago
    Change Detected
    Summary
    Added a glossary display option and updated study metadata to include 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and 'Revision: v3.4.0'. Removed the previous labels 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4'.
    Difference
    0.2%
    Check dated 2026-01-28T21:53:00.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Esophagogastric Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Esophagogastric Cancer Clinical Trial page.